Akebia Therapeutics Inc
NASDAQ:AKBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
|
Kingfisher PLC
F:KFI2
|
UK |
|
Heidelberg Pharma AG
XETRA:HPHA
|
DE |
|
E
|
E.ON SE
PSE:EOAN
|
DE |
|
Liberty Global PLC
NASDAQ:LBTYA
|
UK |
Wall St Price Targets
AKBA Price Targets Summary
Akebia Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AKBA is 4.08 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKBA's stock price target?
Price Target
4.08
USD
According to Wall Street analysts, the average 1-year price target for AKBA is 4.08 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Akebia Therapeutics Inc?
Projected CAGR
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for Akebia Therapeutics Inc?
Projected CAGR
-6%
The compound annual growth rate for Gross Profit over the next 3 years is -6%.
What is the Operating Income forecast for Akebia Therapeutics Inc?
Projected CAGR
34%
The compound annual growth rate for Operating Income over the next 8 years is 34%.
